| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A game-changer for PrEP if access is adequate
|
The Lancet HIV,
|
|
|
11 |
9 |
p. e567
|
article
|
| 2 |
GHESKIO's model of patient care during civil unrest in Haiti
|
Deschamps, Marie Marcelle
|
|
|
11 |
9 |
p. e572-e573
|
article
|
| 3 |
Highlights from the 25th International AIDS Conference
|
Hayward, Peter
|
|
|
11 |
9 |
p. e574
|
article
|
| 4 |
IAPAC–Lancet HIV Commission on the future of urban HIV responses
|
Zuniga, José M
|
|
|
11 |
9 |
p. e607-e648
|
article
|
| 5 |
Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohort
|
Llibre, Josep M
|
|
|
11 |
9 |
p. e598-e606
|
article
|
| 6 |
Impact of financial incentives on viral suppression among adults initiating HIV treatment in Tanzania: a hybrid effectiveness–implementation trial
|
Njau, Prosper F
|
|
|
11 |
9 |
p. e586-e597
|
article
|
| 7 |
Incentivising engagement in care among people with HIV
|
Smith, P J
|
|
|
11 |
9 |
p. e569-e570
|
article
|
| 8 |
No money, no treatment—living on the edge
|
Burki, Talha
|
|
|
11 |
9 |
p. e575
|
article
|
| 9 |
Optimising anal cancer screening through risk stratification
|
Sendagorta, Elena
|
|
|
11 |
9 |
p. e570-e572
|
article
|
| 10 |
Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study
|
Oomen, Patrick G A
|
|
|
11 |
9 |
p. e576-e585
|
article
|
| 11 |
Where does doravirine fit in current antiretroviral therapy?
|
Sinxadi, Phumla
|
|
|
11 |
9 |
p. e568-e569
|
article
|
Journal description